Cargando…
Taming the cytokine storm: repurposing montelukast for the attenuation and prophylaxis of severe COVID-19 symptoms
As a result of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections, a clinical complication can arise that is characterized by a hyperinflammatory cytokine profile, often termed a ‘cytokine storm’. A protein complex (nuclear factor kappa-light-chain-enhancer of activated B cells;...
Autores principales: | Sanghai, Nitesh, Tranmer, Geoffrey K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7493735/ https://www.ncbi.nlm.nih.gov/pubmed/32949526 http://dx.doi.org/10.1016/j.drudis.2020.09.013 |
Ejemplares similares
-
Hydrogen Peroxide and Amyotrophic Lateral Sclerosis: From Biochemistry to Pathophysiology
por: Sanghai, Nitesh, et al.
Publicado: (2021) -
Biochemical and Molecular Pathways in Neurodegenerative Diseases: An Integrated View
por: Sanghai, Nitesh, et al.
Publicado: (2023) -
Taming the storm
por: Burstyn-Cohen, Tal, et al.
Publicado: (2021) -
Calming the cytokine storm of COVID-19 through inhibition of JAK2/STAT3 signaling
por: Gajjela, Bharath Kumar, et al.
Publicado: (2022) -
2648. Taming the Cytokine Storm: Baricitinib versus Tocilizumab for COVID-19 Hyperinflammation
por: Radziszewski, Skyler, et al.
Publicado: (2023)